167 related articles for article (PubMed ID: 21995660)
21. Structural Differences Influence Biological Properties of Glucosylceramides from Clinical and Environmental Isolates of
Caneppa A; de Meirelles JV; Rollin-Pinheiro R; Dutra Xisto MIDS; Liporagi-Lopes LC; Souza L; Villela Romanos MT; Barreto-Bergter E
J Fungi (Basel); 2019 Jul; 5(3):. PubMed ID: 31311197
[No Abstract] [Full Text] [Related]
22. Distribution of the different species of the Pseudallescheria boydii/Scedosporium apiospermum complex in French patients with cystic fibrosis.
Zouhair R; Rougeron A; Razafimandimby B; Kobi A; Bouchara JP; Giraud S
Med Mycol; 2013 Aug; 51(6):603-13. PubMed ID: 23461512
[TBL] [Abstract][Full Text] [Related]
23. Characterization of glucosylceramides in Pseudallescheria boydii and their involvement in fungal differentiation.
Pinto MR; Rodrigues ML; Travassos LR; Haido RM; Wait R; Barreto-Bergter E
Glycobiology; 2002 Apr; 12(4):251-60. PubMed ID: 12042248
[TBL] [Abstract][Full Text] [Related]
24. A peptidorhamnomannan from the mycelium of Pseudallescheria boydii is a potential diagnostic antigen of this emerging human pathogen.
Pinto MR; Mulloy B; Haido RMT; Travassos LR; Barreto Bergter E
Microbiology (Reading); 2001 Jun; 147(Pt 6):1499-1506. PubMed ID: 11390680
[TBL] [Abstract][Full Text] [Related]
25. Pseudallescheria boydii releases metallopeptidases capable of cleaving several proteinaceous compounds.
Silva BA; Pinto MR; Soares RM; Barreto-Bergter E; Santos AL
Res Microbiol; 2006 Jun; 157(5):425-32. PubMed ID: 16487686
[TBL] [Abstract][Full Text] [Related]
26. Chronic sino-naso-orbital fungal infection due to Pseudallescheria boydii in a nonimmunocompromised host--a case report.
Sateesh CS; Makannavar JH
Indian J Pathol Microbiol; 2001 Jul; 44(3):359-61. PubMed ID: 12024935
[TBL] [Abstract][Full Text] [Related]
27. Characterization of pseudacyclins A-E, a suite of cyclic peptides produced by Pseudallescheria boydii.
Pavlaskova K; Nedved J; Kuzma M; Zabka M; Sulc M; Sklenar J; Novak P; Benada O; Kofronova O; Hajduch M; Derrick PJ; Lemr K; Jegorov A; Havlicek V
J Nat Prod; 2010 Jun; 73(6):1027-32. PubMed ID: 20509707
[TBL] [Abstract][Full Text] [Related]
28. Ecology of Pseudallescheria and Scedosporium species in human-dominated and natural environments and their distribution in clinical samples.
Kaltseis J; Rainer J; De Hoog GS
Med Mycol; 2009 Jun; 47(4):398-405. PubMed ID: 19085459
[TBL] [Abstract][Full Text] [Related]
29. Re-identification of clinical isolates of the Pseudallescheria boydii-complex involved in near-drowning.
Tintelnot K; Wagner N; Seibold M; de Hoog GS; Horré R
Mycoses; 2008 Sep; 51 Suppl 3():11-6. PubMed ID: 18782237
[TBL] [Abstract][Full Text] [Related]
30. Abundance of Pseudallescheria/Scedosporium species in the Australian urban environment suggests a possible source for scedosporiosis including the colonization of airways in cystic fibrosis.
Harun A; Gilgado F; Chen SC; Meyer W
Med Mycol; 2010 Nov; 48 Suppl 1():S70-6. PubMed ID: 21067333
[TBL] [Abstract][Full Text] [Related]
31. An alpha-glucan of Pseudallescheria boydii is involved in fungal phagocytosis and Toll-like receptor activation.
Bittencourt VC; Figueiredo RT; da Silva RB; Mourão-Sá DS; Fernandez PL; Sassaki GL; Mulloy B; Bozza MT; Barreto-Bergter E
J Biol Chem; 2006 Aug; 281(32):22614-23. PubMed ID: 16766532
[TBL] [Abstract][Full Text] [Related]
32. Cell wall modifications during conidial maturation of the human pathogenic fungus Pseudallescheria boydii.
Ghamrawi S; Rénier G; Saulnier P; Cuenot S; Zykwinska A; Dutilh BE; Thornton C; Faure S; Bouchara JP
PLoS One; 2014; 9(6):e100290. PubMed ID: 24950099
[TBL] [Abstract][Full Text] [Related]
33. Granulomatous and eosinophilic rhinitis in a cow caused by Pseudallescheria boydii species complex (Anamorph Scedosporium apiospermum).
Singh K; Boileau MJ; Streeter RN; Welsh RD; Meier WA; Ritchey JW
Vet Pathol; 2007 Nov; 44(6):917-20. PubMed ID: 18039905
[TBL] [Abstract][Full Text] [Related]
34. Tracking the emerging human pathogen Pseudallescheria boydii by using highly specific monoclonal antibodies.
Thornton CR
Clin Vaccine Immunol; 2009 May; 16(5):756-64. PubMed ID: 19321690
[TBL] [Abstract][Full Text] [Related]
35. Scedosporium apiospermum (Pseudallescheria boydii) endocarditis.
O'Bryan TA; Browne FA; Schonder JF
J Infect; 2002 Apr; 44(3):189-92. PubMed ID: 12099748
[TBL] [Abstract][Full Text] [Related]
36. Fungal arthritis due to Pseudallescheria boydii (Scedosporium apiospermum).
Dellestable F; Kures L; Mainard D; Pere P; Gaucher A
J Rheumatol; 1994 Apr; 21(4):766-8. PubMed ID: 8035409
[TBL] [Abstract][Full Text] [Related]
37. Molecular taxonomy and ecology of Pseudallescheria, Petriella and Scedosporium prolificans (Microascaceae) containing opportunistic agents on humans.
Rainer J; De Hoog GS
Mycol Res; 2006 Feb; 110(Pt 2):151-60. PubMed ID: 16388940
[TBL] [Abstract][Full Text] [Related]
38. Reverse line blot hybridisation screening of Pseudallescheria/Scedosporium species in patients with cystic fibrosis.
Lu Q; van den Ende AH; de Hoog GS; Li R; Accoceberry I; Durand-Joly I; Bouchara JP; Hernandez F; Delhaes L
Mycoses; 2011 Oct; 54 Suppl 3():5-11. PubMed ID: 21995657
[TBL] [Abstract][Full Text] [Related]
39. Molecular and phenotypic data supporting distinct species statuses for Scedosporium apiospermum and Pseudallescheria boydii and the proposed new species Scedosporium dehoogii.
Gilgado F; Cano J; Gené J; Sutton DA; Guarro J
J Clin Microbiol; 2008 Feb; 46(2):766-71. PubMed ID: 18077629
[TBL] [Abstract][Full Text] [Related]
40. A Multifaceted Study of Scedosporium boydii Cell Wall Changes during Germination and Identification of GPI-Anchored Proteins.
Ghamrawi S; Gastebois A; Zykwinska A; Vandeputte P; Marot A; Mabilleau G; Cuenot S; Bouchara JP
PLoS One; 2015; 10(6):e0128680. PubMed ID: 26038837
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
